Hamps Bio board to consider FY26 results on May 29
Hamps Bio Limited will hold a board meeting on May 29, 2026, to approve audited financial results for the half-year and year ended March 31, 2026. The board will also consider appointing Naviwala & Associates, Surat as internal auditor for FY27.

*this image is generated using AI for illustrative purposes only.
Hamps Bio Limited has scheduled a board meeting on Friday, May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the half-year and year ended March 31, 2026. The meeting will be held at the company's corporate office. The board will also deliberate on the appointment of Naviwala & Associates, Surat as the internal auditor for the financial year 2026-2027.
The intimation was submitted to BSE Limited in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015. The agenda includes the consideration of any other business with the permission of the Chair.
Agenda Items
The board meeting will focus on the following key matters:
- Consideration and approval of audited standalone and consolidated financial results for the half-year and year ended March 31, 2026.
- Appointment of Naviwala & Associates, Surat as internal auditor for FY27.
- Any other business with the permission of the Chair.
Company Details
| Attribute | Details |
|---|---|
| Scrip Code | 544312 |
| CIN No. | L24233GJ2007PLC049692 |
| Managing Director & Chairman | Herrick Mountbaton Shah |
| DIN | 01052316 |
Historical Stock Returns for Hamps Bio
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.96% | -0.26% | +3.69% | +10.12% | +16.68% | -48.02% |
How will the audited financial results for FY26 impact Hamps Bio's stock performance and investor sentiment?
What strategic initiatives or growth plans might the board discuss under 'any other business'?
Could the appointment of Naviwala & Associates as internal auditor signal a shift in the company's compliance or governance practices?
































